
- Pharmaceutical Technology's In the Lab eNewsletter, June 2022
- Volume 17
- Issue 6
Sferalp to Use Fluid Air Technology for Laboratory Research
Sferalp will use Fluid Air’s PolarDry technology for powder processing.
Fluid Air, a division of Spraying Systems, announced that Sferalp, the R&D arm of Micro-Sphere, has selected their PolarDry technology for use in its research laboratory in Monteggio, Switzerland. Sferalp will use the PolarDry technology for powder processing with its commercial food, pharmaceutical, and nutraceutical customers.
“Our Swissmedic-certified laboratory is authorized to perform chemical-physical quality control tests on medicinal products and active substances in accordance with [good manufacturing practices] for medicinal products, and we know that we can count on Fluid Air technology to help achieve superior results for our customers,” said Michele Müller, general manager of Sferalp, in a May 10, 2022 company press release. “Fluid Air is the only provider in the marketplace whose technology can support our lab’s needs and help us meet the highest industry standards for quality and product performance.”
“Fluid Air is pleased to have its PolarDry technology used by an industry influencer [such as] Sferalp [and] is thrilled to have been selected as a key technology contributor to Sferalp[’s] important work,” said Michel Thenin, president, Fluid Air, in the press release.
Source:
Articles in this issue
over 3 years ago
Dissolution Testing Sees Advancesover 3 years ago
Ensuring CGMP Standards for Data Integrityover 3 years ago
PerkinElmer Introduces Ultrarapid Whole Genome Sequencingover 3 years ago
PAMM Foundation Outsources Laboratory Activities to Eurofinsover 3 years ago
Avacta Establishes New Therapeutics HeadquartersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





